Wuxi Biologics

WuXi Biologics is a Hong Kong-based company specializing in the research, development and manufacture of world-leading biopharmaceuticals. The company believes that every drug can be made and every disease can be treated. To realize this vision, WuXi Biologics has built an open platform with the most advanced capabilities and technologies in the biologics industry.

WuXi Biologics' goal is to accelerate and transform the discovery, development and manufacture of biopharmaceuticals, making them accessible to patients worldwide. The company offers end-to-end research, development and manufacturing services for monoclonal antibodies, vaccines and other biologics to its global customers.

WuXi Biologics attaches great importance to environmental, social and governance (ESG) responsibilities and integrates them into its ethics and business strategy. It strives to become an ESG leader in the field of Contract Research and Development Manufacturing Organization (CRDMO) biologics. Its facilities use new-generation bioproduction technologies and clean energy sources. In addition, the company has established an ESG committee headed by its Managing Director to oversee global ESG strategy and implementation, demonstrating its commitment to sustainability.